Printer Friendly
The Free Library
14,560,361 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Fuji Keizai Releases Report on Japanese Immunoassay Market.


Tokyo, Japan, Jan 19, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
) - Japanese market researcher Fuji Keizai has published a report on the immunoassay Immunoassay

An assay that quantifies antigen or antibody by immunochemical means. The antigen can be a relatively simple substance such as a drug, or a complex one such as a protein or a virus.
 market in Japan.

The report estimates that the market for diagnostic products reached about 327.5 billion yen ($2.85 bil) in 2005, of which the immunoassay sector accounted for a little under 50%, reaching 154 billion yen ($1.33 bil).

In particular, the influenza antigen rapid test kit sector demonstrated significant growth. In line with the flu epidemic in 2004, it is expected to have reached 15.5 billion yen ($134.7 mil) in 2005, up from 10 billion yen ($87.0 mil) in 2003.

In addition, three segments in the immunoassay market showed sound growth. They are chemiluminescent chem·i·lu·mi·nes·cence  
n.
Emission of light as a result of a chemical reaction at environmental temperatures.



chem
 assay, latex assay and immunochromato/gold colloid colloid (kŏl`oid) [Gr.,=gluelike], a mixture in which one substance is divided into minute particles (called colloidal particles) and dispersed throughout a second substance.  assay.

Entitled Immunoassay Market 2006, the 292-page report (available only in Japanese) sells for 200,000 yen ($1,740).

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Jan 21, 2006
Words:154
Previous Article:GlaxoSmithKline Japan to Markey New Acute Otitis Media Drug Clavamox Dry Syrup.
Next Article:Nihon Canpack Opens New Aseptic Plastic Bottle Packaging Plant.



Related Articles
THIRD GEN MOBILE TECH REPORT NOW AVAILABLE FROM MRG, INC.(Industry Trend or Event)
Fuji Keizai Releases Report on Specified Health Food Market in Japan.
Fuji Keizai Analyzes Functional Cosmetics Market in Japan.
Fuji Keizai Analyzes Health/Beauty-oriented Food Market in Japan.
Fuji Keizai Releases Report on Skin Care Product Trends in Japan.
Fuji Keizai Releases Reports on Japanese Health and Beauty Food Market.
Fuji Keizai Releases Report on Japanese Cosmetics Market.
Fuji Keizai Releases Reports on Water Resource Market in Japan.
Fuji Keizai Releases Reports on OTC Drug Market in Japan.
Fuji Keizai Releases Report on Soft Drink Market in Japan.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles